Chronic Kidney Disease

The SGLT2 inhibitor dapagliflozin was associated with a reduced risk for hospitalization due to any cause in patients with chronic kidney disease with and without type 2 diabetes, according to a post hoc analysis of the DAPA-CKD trial.

ORLANDO — Patients with advanced chronic kidney disease who choose conservative management have lower hospitalization rates vs. patients who choose dialysis, according to a study presented at ASN Kidney Week.

Compared with vegan and lacto-ovo low-protein diets for those with chronic kidney disease, an omnivorous low-protein diet is less likely to be deficient in essential amino acids and nutrients, findings in the Journal of Renal Nutrition show.

The American Kidney Fund announced the launch of its Patient Access Initiative in a press release. The initiative aims to provide insight and solutions to health care access issues among patients with kidney disease and their caregivers.

In this video, Paula LeClair, MBA, MHCDS, U.S. general manager at Healthy.io and chairperson for the American Diabetes Association Board in New England, discusses how the Minuteful Kidney test can improve screening adherence for chronic kidney disease.

ORLANDO — Clinicians who asked themselves, “Would I be surprised if this patient transferred from peritoneal dialysis to hemodialysis within 6 months?” helped them identify patients at risk, according to a presentation at ASN Kidney Week.

ORLANDO — In this video from ASN Kidney Week, Jula Inrig, MD, chief medical officer of Travere Therapeutics Inc., discusses the use of dapagliflozin with sparsentan as treatment for IgA nephropathy and focal segmental glomerulosclerosis.

Sarcopenic obesity may increase the risk for chronic kidney disease among adults with type 2 diabetes, but low muscle mass without obesity was not associated with CKD, according to study results published in Obesity.

ORLANDO — In this video from ASN Kidney Week, Jonathan Barratt, MBChB, PhD, discusses Calliditas Therapeutics’ Tarpeyo treatment, previously known as Nefecon, for patients with IgA nephropathy.

ORLANDO — In Black adults with hypertension and chronic kidney disease, coaching about purchasing food with high potassium improved diet quality and albuminuria, according to a presenter at ASN Kidney Week.